Do urine heteroplasmy rates predict the outcome of the m.3243A>G mutation?

Josef Finsterer, MD, PhD (1) , Fulvio A. Scorza, MD (2)
(1) Krankenanstalt Rudolfstiftung, Messerli Institute, Veterinary University of Vienna, Vienna, Austria , Austria
(2) Disciplina de Neurociência. Escola Paulista de Medicine/Universidade Federal de São Paulo/. (EPM/UNIFESP). São Paulo, Brasil. , Austria
https://doi.org/10.15520/jcmro.v1i09.107

Article Sidebar

Issue
Vol. 1 No. 09 (2018)
PDF

Abstract

In a recent study, Fayssoil et al. investigated the relation between serum/urine heteroplasmy rates and clinical manifestations at onset and major adverse events (MAE) during follow-up in a retrospective study of 43 patients carrying the m.3243A>G mutation1 MAE included strokelike episodes (SLEs), status epilepticus, heart failure, renal failure, and intestinal pseudo-obstruction1 We want to add some comments and concerns.

Full text article

Generated from XML file

References

.

Authors

Josef Finsterer, MD, PhD
Krankenanstalt Rudolfstiftung, Messerli Institute, Veterinary University of Vienna, Vienna, Austria
Fulvio A. Scorza, MD
Disciplina de Neurociência. Escola Paulista de Medicine/Universidade Federal de São Paulo/. (EPM/UNIFESP). São Paulo, Brasil.
MD, PhD, J. F., & Scorza, MD, F. A. (2018). Do urine heteroplasmy rates predict the outcome of the m.3243A>G mutation?. Journal of Current Medical Research and Opinion, 1(09), 40–41. https://doi.org/10.15520/jcmro.v1i09.107
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX
Copyright and license info is not available

Article Details